EUVIMEDEUVIMED entdecken
Crossref

A Simple HPLC-UV Method for Ivosidenib Determination in Human Plasma

Yoshito Gando, Takeo Yasu

Journal of Chromatographic Science · 2024

DOI: 10.1093/chromsci/bmad082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2024. Verfasst von Yoshito Gando und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tok…. Hauptthemen laut MEDLINE: Pyridines, Glycine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivosidenib is used for the treatment of acute myeloid leukemia (AML) with isocitrate dehydrogenase 1 (IDH1) mutations. However, increased blood concentrations of ivosidenib are associated with a risk of a prolonged QT interval in patients with AML. Therapeutic drug monitoring in patients with AML with IDH1 mutation offers the potential to improve treatment efficacy while minimizing toxicity. In this study, we developed an efficient high-performance liquid chromatography–ultraviolet (HPLC-UV) method for the quantification of ivosidenib in plasma. Human plasma samples (50 μL) were processed by protein precipitation using acetonitrile, followed by chromatographic separation on a reversed-phase column with an isocratic mobile phase of 0.5% KH₂PO₄ (pH 4.5) and acetonitrile (45:55, v/v) at a flow rate of 1.0 mL/min, with ultraviolet detection at 245 nm. Calibration curves were linear over the range of 0.25–20 μg/mL with a coefficient of determination (r2) of 0.99999. Intra-day and inter-day precision were 1.20–8.04% and 0.69–4.20%, respectively. The assay accuracy was −2.00% to 1.93% and recovery was >91.2%. These findings support the effectiveness of the newly developed HPLC-UV method for the quantification of ivosidenib in human plasma. This simple and cost-effective method is expected to expand ivosidenib monitoring in laboratories lacking LC–MS/MS instruments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridinesGlycineHumansChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsLimit of DetectionSpectrophotometry, Ultraviolet

Substanzen

ivosidenibPyridinesGlycine

Autor:innen und Institutionen

  • Department of Medicinal Therapy Research, Pharmaceutical Education and Research Center, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo 204-8588, Japan.

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Gando, Y., & Yasu, T. (2024). A Simple HPLC-UV Method for Ivosidenib Determination in Human Plasma. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmad082

Vancouver

Gando Y, Yasu T. A Simple HPLC-UV Method for Ivosidenib Determination in Human Plasma. Journal of Chromatographic Science. 2024. doi:10.1093/chromsci/bmad082

BibTeX
@article{Gando2024,
  author = {Gando, Yoshito and Yasu, Takeo},
  title = {A Simple HPLC-UV Method for Ivosidenib Determination in Human Plasma},
  journal = {Journal of Chromatographic Science},
  year = {2024},
  doi = {10.1093/chromsci/bmad082}
}
Kostenlos starten →